NOTCH2 and B-cell chronic lymphocytic leukemia: We observed a significant reduction of CLL cell viability when venetoclax was combined with Notch2 siRNA compared to combination with scramble control (Figure 5A; n = 4, *p < 0.05, **p < 0.01).